Type 2 diabetes
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Type 2 diabetes 2)type 2 patients who taking metformin within the conditions specified in the product labeling
Exclusion criteria
Exclusion criteria: 1)Is receiving vitamin B12 preparation including vitamin B12 supplements 2)Is receiving steroids, and gastrectomy (include segmentectomy and total resection, but not endoscopic mucosal resection) 3)Is pregnant, nursing, or planned to become pregnant 4)With malabsorption(chronic pancreatitis,inflammatory bowel disease and malabsorption syndrome) 5)With severe infection, pre or post surgery, and serious trauma,malignancy 6)With renal dysfunction (Serum Creatinine male: >= 1.5 mg/dL, female: >= 1.3 mg/dL) 7)Considered as inadequate by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The corelation between the period of taking metformin and serum homocysteine or vitamin B12 level as the diagnostic index for vitamin B12 deficiency. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)The corelation between the daily dose of metformin and serum homocysteine or vitamin B12 level as the diagnostic index for vitamin B12 deficiency. 2)The corelation between the cumulative dose of metformin and serum homocysteine or vitamin B12 level. 3)The relationship between macrocytic anemia and serum homocysteine or vitamin B12 level. | — |
Countries
Japan
Contacts
Kobe University Graduate School of Medicine Division of Diabetes and Endocrinology